We are live on
!
Find out more
NFG
Noven Financial Group Portfolio holdings
AUM
$123M
1-Year Est. Return
5.23%
This Fund
S&P 500
This Quarter
Est. Return
+5.01%
1 Year Est. Return
+5.23%
3 Year Est. Return
+45.07%
5 Year Est. Return
+66.39%
10 Year Est. Return
–
AUM
$145M
AUM Growth
–
Cap. Flow
+$144M
Cap. Flow
% of AUM
99.12%
Top 10 Holdings %
Top 10 Hldgs %
81.75%
Holding
30
New
29
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
+$29.4M |
| 2 |
iShares Russell 2000 Growth ETF
IWO
|
+$15.9M |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$12.1M |
| 4 |
iShares Russell 2000 Value ETF
IWN
|
+$12M |
| 5 |
Vanguard Mid-Cap Growth ETF
VOT
|
+$12M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.43% |
| 2 | Technology | 0.8% |
| 3 | Financials | 0.3% |
| 4 | Communication Services | 0.21% |
| 5 | Real Estate | 0.21% |
Similar funds
SI
AIS
JAM
FAM
BBA
SCM
CFW
PCM
Noven Financial Group's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Noven Financial Group, which disclosed 30 positions worth $145M. Its ten largest holdings account for 82% of the portfolio.
Its largest position is Ampio Pharmaceuticals Inc.: 12,450 shares worth $26.6M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, followed by Technology and Financials.
- Noven Financial Group's largest Q4 2013 buy was Ampio Pharmaceuticals Inc.: 12,450 shares worth $26.6M.
- Noven Financial Group's ten largest holdings make up 82% of its $145M portfolio in Q4 2013.
- Noven Financial Group disclosed 30 positions in Q4 2013, its first 13F filing on record.
Based on Noven Financial Group's 13F filing for Q4 2013, filed 4 Feb 2014.